Overview
Paivi Myllynen practices in Oulu, Finland. Myllynen is rated as an Advanced expert by MediFind in the treatment of PEPCK 1 Deficiency. Their top areas of expertise are PEPCK 1 Deficiency, Trophoblastic Tumor Placental Site, Infant Epilepsy with Migrant Focal Crisis, and Glutaric Acidemia Type 2.
Their clinical research consists of co-authoring 25 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 2 articles in the study of PEPCK 1 Deficiency.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- PEPCK 1 DeficiencyMyllynen isAdvanced. Learn about PEPCK 1 Deficiency.
- Trophoblastic Tumor Placental Site
- Experienced
- Childhood PancreatitisMyllynen isExperienced. Learn about Childhood Pancreatitis.
- ChoriocarcinomaMyllynen isExperienced. Learn about Choriocarcinoma.
- Genetic Epilepsy with Febrile Seizures Plus (GEFS+)
- Glutaric Acidemia Type 2Myllynen isExperienced. Learn about Glutaric Acidemia Type 2.
- Infant Epilepsy with Migrant Focal Crisis
- Low Blood SugarMyllynen isExperienced. Learn about Low Blood Sugar.